The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Love, P. E.
Right arrow Articles by Shores, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Love, P. E.
Right arrow Articles by Shores, E. W.
The Journal of Immunology, 00, 165: 3080-3087.
Copyright © 00 by The American Association of Immunologists

Critical Relationship Between TCR Signaling Potential and TCR Affinity During Thymocyte Selection

Paul E. Love*, Jan Lee1,{dagger} and Elizabeth W. Shores2,{dagger}

* Laboratory of Mammalian Genes & Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and {dagger} Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892

Whether a developing thymocyte becomes positively or negatively selected is thought to be determined by the affinity/avidity of its TCR for MHC/peptide ligands expressed in the thymus. Presumably, differences in affinity translate into differences in the potency of the ensuing TCR-mediated signals, and these differences in signal strength determine the outcome of thymocyte selection. However, there is little direct evidence establishing a relationship between TCR-ligand affinity and signal strength during positive and negative selection. The TCR complex contains multiple signaling motifs, known as immunoreceptor tyrosine-based activation motifs (ITAMs) that are required for T cell activation. To examine the effects of TCR signal strength on selection, the signaling potential of the TCR was modified by substituting transgenic TCR {zeta}-chains containing either three, one, or zero ITAMs for endogenous (3-ITAM) {zeta}-chain. These {zeta}-chain variants were then bred into different {alpha}ßTCR transgenic backgrounds. We report that reductions in TCR signaling potential have distinct effects on the selection of thymocytes expressing different TCRs, and that the requirement for {zeta}-chain ITAMs critically depends upon the specificity and apparently, affinity, of the TCR for its selecting ligand(s).




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. E. Keir, Y. E. Latchman, G. J. Freeman, and A. H. Sharpe
Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes
J. Immunol., December 1, 2005; 175(11): 7372 - 7379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Pitcher, M. A. Mathis, S. Subramanian, J. A. Young, E. K. Wakeland, P. E. Love, and N. S. C. van Oers
Selective Expression of the 21-Kilodalton Tyrosine-Phosphorylated Form of TCR {zeta} Promotes the Emergence of T Cells with Autoreactive Potential
J. Immunol., May 15, 2005; 174(10): 6071 - 6079.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Pitcher, P. S. Ohashi, and N. S. C. van Oers
T Cell Antagonism is Functionally Uncoupled from the 21- and 23-kDa Tyrosine-Phosphorylated TCR {zeta} Subunits
J. Immunol., July 15, 2003; 171(2): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Lucas, L. O. Atherly, and L. J. Berg
The Absence of Itk Inhibits Positive Selection Without Changing Lineage Commitment
J. Immunol., June 15, 2002; 168(12): 6142 - 6151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Spain and P. Liu
TCR{beta} Transmembrane Tyrosines Are Required for Pre-TCR Function
J. Immunol., January 1, 2002; 168(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Magnan, V. Di Bartolo, A.-M. Mura, C. Boyer, M. Richelme, Y.-L. Lin, A. Roure, A. Gillet, C. Arrieumerlou, O. Acuto, et al.
T Cell Development and T Cell Responses in Mice with Mutations Affecting Tyrosines 292 or 315 of the ZAP-70 Protein Tyrosine Kinase
J. Exp. Med., August 20, 2001; 194(4): 491 - 506.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. S. Azzam, J. B. DeJarnette, K. Huang, R. Emmons, C.-S. Park, C. L. Sommers, D. El-Khoury, E. W. Shores, and P. E. Love
Fine Tuning of TCR Signaling by CD5
J. Immunol., May 1, 2001; 166(9): 5464 - 5472.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.